Workplace Drug Testing During a Pandemic: What Should Employers Know?

Yes, employers generally retain the right to conduct workplace drug testing during a pandemic or public health emergency, though the logistics and legal considerations require careful navigation. Pre-employment drug testing may be deferred if candidates are not yet physically on-site, but employers should apply deferral policies consistently to avoid discrimination claims. Random and reasonable-suspicion drug testing can continue during a pandemic, with appropriate safety protocols in place for in-person collection. Some jurisdictions have expanded medical marijuana protections and off-duty conduct laws in recent years, which may limit an employer's ability to act on a positive test result. Employers should review their drug testing policies in light of current state law, ensure testing procedures comply with ADA guidelines where medical conditions are involved, and consult legal counsel before modifying programs during emergency periods.

The rapid expansion of state marijuana legalization—both medical and recreational—has significantly complicated employer drug testing programs. As of 2025, a growing number of states have enacted off-duty conduct laws or employment protections for medical marijuana users that restrict employers from taking adverse action based solely on a positive THC test, even where federal law still classifies marijuana as a controlled substance. This creates a complex patchwork: employers in federally regulated industries (DOT, federal contractors) must still enforce zero-tolerance policies, while private employers in states with employee protections must carefully evaluate the circumstances of any positive test. Key employer considerations include whether the employee was impaired at work, whether the role is safety-sensitive, and whether the state offers legal protections. Regular policy reviews and legal counsel consultation are essential as this landscape continues to evolve.

Employers have several drug testing options, each appropriate for different circumstances. Pre-employment testing screens candidates before they begin work and is common in safety-sensitive industries. Random testing deters ongoing drug use and is required for DOT-regulated employees; it must use a genuinely random selection process to be defensible. Reasonable-suspicion testing is triggered by specific, documented observations of impaired behavior and requires supervisory training to administer properly. Post-accident testing occurs after a workplace incident and must be tied to a plausible nexus between drug use and the accident to withstand legal scrutiny. Return-to-duty and follow-up testing applies to employees who have completed substance abuse programs. Each type carries specific legal requirements, and employers should have clearly written policies explaining when each applies, what the consequences of a positive result are, and what employee rights exist in the testing process.

Poorly administered drug testing programs expose employers to several legal risks. Inconsistent application of testing policies—such as testing only certain demographic groups—can give rise to discrimination claims under Title VII or the ADA. The ADA also protects employees who are in recovery from addiction from being discriminated against based on their history of substance use, provided they are no longer actively using. Employees prescribed legal medications that may trigger a positive test may have ADA accommodation rights if a disability underlies the prescription. State-level marijuana and off-duty conduct protections increasingly restrict employer discretion to discipline or terminate based on positive tests alone. Privacy laws in some states regulate how drug test results may be used and stored. To manage these risks, employers should work with legal counsel to develop clearly written, consistently enforced drug testing policies that are regularly updated to reflect current law.

When an employee tests positive for drugs, HR should follow a documented, consistent process grounded in company policy and applicable law. First, confirm the result through a Medical Review Officer (MRO) who can assess whether a legal prescription or medical condition explains the positive result. Before taking adverse action, review the employee's role, state law protections, and whether an ADA accommodation analysis is warranted. If disciplinary action is appropriate, it should align with the written policy and be applied consistently across similarly situated employees. Many organizations offer an Employee Assistance Program (EAP) referral and a last-chance agreement allowing the employee to complete a substance abuse program and return to work under a return-to-duty protocol. Thorough documentation of every step—from the initial test through any disciplinary or rehabilitation steps—is critical to defending the company's actions if the employee later files a legal claim.